Literature DB >> 10920312

Influence of oxytocin on prostaglandin E2, intracellular calcium, and cyclic adenosine monophosphate in human amnion-derived (WISH) cells.

B Pavan1, M Buzzi, F Ginanni-Corradini, M E Ferretti, F Vesce, C Biondi.   

Abstract

OBJECTIVE: This study was undertaken to investigate the regulation of prostaglandin release by oxytocin and the influence of oxytocin on intracellular calcium and on the cyclic adenosine monophosphate system in human amnion-derived WISH cells. STUDY
DESIGN: We determined prostaglandin E(2) release from WISH cells treated with oxytocin, evaluated the cytosolic calcium concentration in single WISH cells by confocal microscopy, and measured both intracellular cyclic adenosine monophosphate levels and adenylyl cyclase activity after oxytocin treatment.
RESULTS: Treatment of WISH cells with oxytocin resulted in a concentration-dependent release of prostaglandin E(2), which was increased by lithium chloride and inhibited by indomethacin and U-73122. In single WISH cells, oxytocin increased cytosolic calcium. Moreover, the hormone lowered levels of intracellular cyclic adenosine monophosphate but did not alter adenylyl cyclase activity.
CONCLUSIONS: Our data demonstrate, for the first time, that WISH cells respond to oxytocin by increasing prostaglandin E(2) release. In addition to phospholipase C activation and cytosolic calcium increase, the hormone effect involves also a reduction of the cyclic adenosine monophosphate level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10920312

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  The oxytocin-prostaglandins pathways in the horse (Equus caballus) placenta during pregnancy, physiological parturition, and parturition with fetal membrane retention.

Authors:  Anna Rapacz-Leonard; Mark Leonard; Małgorzata Chmielewska-Krzesińska; Marta Siemieniuch; Tomasz E Janowski
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

2.  Dexmedetomidine and LPS co-treatment attenuates inflammatory response on WISH cells via inhibition of p38/NF-κB signaling pathway.

Authors:  Tae-Sung Kim; Ji-Young Yoon; Cheul-Hong Kim; Eun-Ji Choi; Yeon Ha Kim; Eun-Jung Kim
Journal:  J Dent Anesth Pain Med       Date:  2022-07-26

3.  Anti-inflammatory effects of dexmedetomidine on human amnion-derived WISH cells.

Authors:  Sang-Hun Shin; Jae-Chaul You; Ji-Hye Ahn; Yeon Ha Kim; Ji-Uk Yoon; Ah-Reum Cho; Eun-Jung Kim
Journal:  Int J Med Sci       Date:  2020-09-09       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.